• Madiha Derouazi

     

    Madiha Derouazi founded AMAL Therapeutics in 2012 as a spin-off from the University of Geneva, Switzerland. In the Laboratory of Tumour Immunology she designed and characterized the CPP-based multi-epitopic cancer vaccine that is currently being progressed by AMAL Therapeutics, and allowed her to raise over 37 million CHF.

  • Steve Anavi

    Steve is the Co-founder and President of Qonto, the leading SME neobank in France, where he looks after technology, product, and operations. Prior to Qonto, he co-founded Smok.io (acquired by a Fortune 500), led operations at Groupon and worked at Deloitte Consulting. He holds an MSc in MT from EPFL, and an MBA from INSEAD. On his free time, Steve mentors early-stage startups, and also loves hiking, taking photos, and traveling with his wife and kid..
    Steve is an EPFL Alumnus MT’06.

powered by XING Events

Event organiser: EPFL Alumni - Venturelab - Innogrant
More participants thanks to online event management solutions from XING Events.

Imprint